Indaptus Therapeutics annual depreciation and amortization
2020
2021
2022
2023
2024
2025
Indaptus Therapeutics Depreciation & Amortization Growth & History (INDP)
Indaptus Therapeutics's depreciation and amortization was $0 for fiscal 2025.
View full Indaptus Therapeutics company overviewIndaptus Therapeutics annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $0 | −$735 | — |
| 2024 | 2024-12-31 | $735 | −$549 | −42.76% |
| 2023 | 2023-12-31 | $1,284 | −$497 | −27.91% |
| 2022 | 2022-12-31 | $1,781 | $378 | +26.94% |
| 2021 | 2021-12-31 | $1,403 | $551 | +64.67% |
| 2020 | 2020-12-31 | $852 | — | — |
Indaptus Therapeutics quarterly depreciation and amortization
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | $0 | $0 | — |
| Q3 2025 | 2025-09-30 | $0 | $0 | — |
| Q2 2025 | 2025-06-30 | $0 | $0 | — |
| Q1 2025 | 2025-03-31 | $0 | −$735 | — |
| Q4 2024 | 2024-12-31 | $0 | — | — |
| Q3 2024 | 2024-09-30 | $0 | −$321 | — |
| Q2 2024 | 2024-06-30 | $0 | −$322 | — |
| Q1 2024 | 2024-03-31 | $735 | $414 | +128.97% |
| Q3 2023 | 2023-09-30 | $321 | −$71 | −18.11% |
| Q2 2023 | 2023-06-30 | $322 | −$212 | −39.70% |
| Q1 2023 | 2023-03-31 | $321 | −$213 | −39.89% |
| Q3 2022 | 2022-09-30 | $392 | −$50 | −11.31% |
| Q2 2022 | 2022-06-30 | $534 | $321 | +150.70% |
| Q1 2022 | 2022-03-31 | $534 | $321 | +150.70% |
| Q3 2021 | 2021-09-30 | $442 | — | — |
| Q2 2021 | 2021-06-30 | $213 | — | — |
| Q1 2021 | 2021-03-31 | $213 | — | — |
Indaptus Therapeutics depreciation and amortization trends
Over the last five fiscal years, Indaptus Therapeutics's depreciation and amortization decreased from $852 to $0, a change of −$852. The latest reported quarter, Q4 2025, shows $0.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Indaptus Therapeutics source filings ↗